12/15-Lipoxygenase Is Increased in Alzheimer's Disease: Possible Involvement in Brain Oxidative Stress

American Journal of Pathology

Volumn 164, Issue 5, 2004, Pages 1655-1662

  Praticò, Domenico ^a,b   Zhukareva, Victoria ^a   Yao, Yuemang ^a   Uryu, Kunihiro ^a   Funk, Colin D ^a   Lawson, John A ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Center for Experimental Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE;

AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 1942501585     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63724-8     Document Type: Article

References (39)

1. Clark CM: Clinical manifestation and diagnostic evaluation of patients with Alzheimer's disease. Neurodegenerative Dementias: Clinical Features and Pathological Mechanisms. Edited by CM Clark, JQ Trojanowski. New York, McGraw-Hill, Inc., 2000, pp 95-114
2. Praticò D, Delanty N: Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 2000, 109:577-585
3. Praticò D, Trojanowski JQ: Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 2000, 21:441-445
4. Kuhn H, Thiele B: The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 1999, 449:7-11
5. Funk CD: The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochem Biophys Acta 1996, 1304:65-84
6. Brash AR: Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999, 274:23679-23682
7. Sun D, McDonnel M, Elsea S, Patel PI, Chen XS, Funk CD: Human 12-R lipoxygenase and the mouse ortholog: molecular cloning, expression, and gene chromosomal assignment. J Biol Chem 1998, 273:33540-33547
8. Conrad DJ: The arachidonate 12/15-lipoxygenase: a review of tissue expression and biologic function. Clin Rev Allergy Immunol 1999, 17:71-89
9. Watanabe T, Medina JF, Haeggstrom JZ, Radmark O, Samulesson B: Molecular cloning of a 12-lipoxygenase cDNA from rat brain. Eur J Biochem 1993, 212:605-612
10. Nishiyama M, Watanabe T, Ueda N, Tsukamoto H, Watanabe K: Arachidonate 12-lipoxygenase is localized in neurons, glia cells and endothelial cells of the canine brain. J Histochem Cytochem 1993, 41:111-117
11. Nishiyama M, Oamoto H, Watanabe T, Hori T, Hada T, Ueda N, Yamamoto S, Tsukamoto H, Watanabe K, Kirino T: Localization of arachidonate 12-lipoxygenase in canine brain tissue. J Neurochem 1992, 58:1395-1400
12. 2α in the central nervous system. Prostaglandins 1978, 16:985-988
13. Li Y, Maher P, Schubert D: A role for 12-lipoxygenase in nerve cell death caused by gluthatione depletion. Neuron 1997, 19:453-463
14. Funk CD, Cyrus T: Current perspectives linking 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis. Tr Cardiovasc Med 2001, 11:116-124
15. 2-isoprostanes in Alzheimer's disease; evidence of enhanced lipid peroxidation in vivo. EMBO J 1998, 12:1777-1783
16. 2α-VI in Alzheimer's disease: correlation of a non-invasive index of lipid peroxidation with disease severity. Ann Neurol 2000, 48:809-812
17. Praticò D: Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol 2002, 63:563-567
18. Phelps C, Khachaturian Z, Trojanowski JQ, (Working Group Chairs) NIA/Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease: Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997, 81:S1-S2
19. Braak H, Braak E: Neuropathological staging of Alzheimer's disease changes. Acta Neuropathol (Berl) 1991, 82:239-259
20. 2-isoprostanes in human urine. Proc Natl Acad Sci USA 1999, 96:13381-13386
21. Praticò D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA: Vitamin E suppresses isoprostane generation and reduces atherosclerosis in apolipoprotein E deficient mice. Nat Med 1998, 4:1189-1192
22. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin V, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VMY: Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001, 49:165-175
23. Zhukareva V, Mann D, Pickering-Brown S, Uryu K, Shuck T, Shah K, Grossman M, Miller BL, Hulette CM, Feinstein SC, Trojanowski JQ, Lee VMY: Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological τ isoforms in gray and white matter. Ann Neurol 2002, 51:730-739
24. Chen XS, Kurre U, Jenkins NA, Copeland NG, Funk CD: cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localization of murine 12-lipoxygenases. J Biol Chem 1994, 269:13979-13987
25. Sun D, Funk CD: Disruption of-12/15-lipoxygenase expression in peritoneal macrophages. J Biol Chem 1996, 271:24055-24062
26. Kuhn H, Thiele BJ: The diversity of the lipoxygenase family. FEBS Lett 1999, 449:7-11
27. Piomelli D, Volterra A, Dale N, Siegelbaum SA, Kandell ER, Schwartz JH, Belardetti F: Lipoxygenase metabolites of arachidonic acid as second messengers for pre-synaptic inhibition of Aplysia sensory cells. Nature 1987, 328:38-43
28. Mecocci P, MacGarvey U, Beal MF: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994, 36:747-751
29. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N: Oxidative damage in Alzheimer's. Nature 1996, 328:120-121
30. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997, 17:2653-2657
31. 2-isoprostane concentration in probable AD. Neurology 1999, 52:562-565
32. Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA: 4-Hydroxynonenal-derived advanced lipid peroxidation products are increased in Alzheimer's disease. J Neurochem 1997, 68:2092-2097
33. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML: Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998, 150:40-44
34. Praticò D: Vitamin E: murine studies versus clinical trials. Ital Heart J 2001, 12:878-881
35. Praticò D: Oxidative imbalance and lipid peroxidation in Alzheimer's disease. Drug Dev Res 2002, 56:446-451
36. Praticò D, Uryu K, Leight S, Trojanowski JQ, Lee VM-Y: Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer's disease. J Neurosci 2001, 21:4183-4187
37. Nunomura A, Perry G, Aliev G, Irai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA: Oxidative damage is the earliest event in Alzheimer's disease. J Neuropathol Exp Neurol 2001, 60:759-767
38. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK: Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382
39. Cyrus T, Praticò D, Witztum JL, Rader DJ, FitzGerald GA, Funk CD: Absence of 12/15lypoxygenase decreases lipid peroxidation and atherosclerosis in apoE deficient mice. Circulation 2001, 103:2277-2282